MedPath

Carbetocin Versus Syntometrine for Prevention of Postpartum Hemorrhage After Cesarean Section

Phase 4
Completed
Conditions
Postpartum Hemorrhage
Blood Loss
Interventions
Drug: Syntometrine
Registration Number
NCT02044549
Lead Sponsor
Cairo University
Brief Summary

to compare effectiveness and tolerability of carbetocin versus syntometrine in prevention of Postpartum hemorrhage after cesarean section

Detailed Description

A double blind randomized study conducted on 450 pregnant subjected randomly either to single 100 μg IV dose of carbetocin (150 women) or combination of 5 IU oxytocin and 0.2 mg ergometrine (300 women) after fetal extraction and before placental removal.

Prevention of postpartum haemorrhage (PPH) after cesarean section (CS) had been evaluated by measurement of drop of Hemoglobin and hematocrit, incidence of PPH and number of subjects needed additional oxytocic

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
300
Inclusion Criteria
  • All participants are at 37 - 40 weeks of gestational age
  • Noncomplicated pregnancy.
Exclusion Criteria
  • Participants with placenta previa
  • Patients with coagulopathy
  • preeclamptic women
  • known sensitivity to oxytocin or methergine were excluded

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
SyntometrineSyntometrineIntravenous combination of 5 IU oxytocin and 0.2 mg ergometrine (300 women) after fetal extraction and before placental removal.
carbetocincarbetocinsingle 100 μg IV dose of carbetocin (150 women) after fetal extraction and before placental removal.
Primary Outcome Measures
NameTimeMethod
prevention of post partum hemorrhage after CS24 hours

Number of participants experienced postpartum hemorrhage

Secondary Outcome Measures
NameTimeMethod
side effects of drugs used24 hours

Number of subjects experienced Hemodynamic changes (blood pressure , pulse and respiratory rate ) , GIT side effects as nausea , vomiting and metallic taste, Vasomotor effects as flushing, headache , itching

Trial Locations

Locations (1)

Ahmed Maged

🇪🇬

Cairo, Egypt

© Copyright 2025. All Rights Reserved by MedPath